SCHEMBL25327265

SCHEMBL25327265

N=C(NO)c1cccc(C=O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UNG P13051 1/20 0.56
ALDH1A1 P00352 2/20 0.47
HDAC3 O15379 4/20 0.42
HDAC1 Q13547 4/20 0.42
TRIM24 O15164 1/20 0.41
TRIM33 Q9UPN9 1/20 0.41
SRC P12931 1/20 0.39
TTR P02766 2/20 0.38
HDAC2 Q92769 3/20 0.37
HDAC8 Q9BY41 3/20 0.37
HDAC4 P56524 2/20 0.37
HDAC7 Q8WUI4 2/20 0.37
HDAC6 Q9UBN7 2/20 0.37
HDAC9 Q9UKV0 2/20 0.37
HDAC5 Q9UQL6 2/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
CYP2A6 P11509 1/20 0.37
NCOR2 Q9Y618 1/20 0.36
NAT1 P18440 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4399682 0.85 HDAC1 (0.49) HDAC3HDAC1TTRHDAC2HDAC8
SCHEMBL11029653 0.81 HDAC3 (0.43) UNGHDAC3HDAC1TTRHDAC2
SCHEMBL27210087 0.79 HDAC1 (0.65) UNGALDH1A1HDAC3HDAC1HDAC2
SCHEMBL7433812 0.77 UNG (0.60) UNGALDH1A1F2F10
SCHEMBL2281119 0.76 UNG (0.55) UNGALDH1A1TRIM24TRIM33SRC
Hydrochloric Acid SCHEMBL6816751 0.76 UNG (0.58) UNGF2F10
SCHEMBL28111532 0.75 KDM1A (0.56) ALDH1A1TTRHDAC6KDM4ERAB9A
SCHEMBL9656969 0.75 UNG (0.68) UNGALDH1A1HDAC3HDAC1TRIM24
SCHEMBL2645425 0.75 HDAC8 (0.41) HDAC3HDAC1HDAC2HDAC8HDAC7
SCHEMBL6853599 0.74 UNG (0.73) UNGALDH1A1TRIM24TRIM33SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114105881-B Platelet aggregation inhibitor, and preparation method and application thereof 沈阳海诺威医药科技有限公司 2024-01-26 CN disclosed
EP-3960734-B1 PLATELET AGGREGATION INHIBITOR, PREPARATION AND USES THEREOF SHENYANG HINEWY PHARMACEUTICAL TECH CO LTD (CN) 2023-10-11 EP disclosed
US-11713300-B2 Platelet aggregation inhibitor, preparation and uses thereof SHENYANG HINEWY PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2023-08-01 US disclosed
CN-114105881-A Platelet aggregation inhibitor and preparation method and application thereof 沈阳海诺威医药科技有限公司 2022-03-01 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11713300-B2 Platelet aggregation inhibitor, preparation and uses thereof TFPI, F12, TFPI2 UNG 3133/4885ALDH1A1 1546/4885HDAC3 3516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.